Global Transdermal Drug Delivery System Supply, Demand and Key Producers, 2024-2030

Description

The global Transdermal Drug Delivery System market size is expected to reach $ 35850 million by 2030, rising at a market growth of 12.7% CAGR during the forecast period (2024-2030).

Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.

In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

This report studies the global Transdermal Drug Delivery System demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Transdermal Drug Delivery System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transdermal Drug Delivery System that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Transdermal Drug Delivery System total market, 2019-2030, (USD Million)
Global Transdermal Drug Delivery System total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Transdermal Drug Delivery System total market, key domestic companies and share, (USD Million)
Global Transdermal Drug Delivery System revenue by player and market share 2019-2024, (USD Million)
Global Transdermal Drug Delivery System total market by Type, CAGR, 2019-2030, (USD Million)
Global Transdermal Drug Delivery System total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Transdermal Drug Delivery System market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku and Bayer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transdermal Drug Delivery System market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Transdermal Drug Delivery System Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Transdermal Drug Delivery System Market, Segmentation by Type
    Fentanyl
    Nitroglycerin
    Estradiol
    Nicotine
    Other

Global Transdermal Drug Delivery System Market, Segmentation by Application
    OTC
    Rx

Companies Profiled:
    Hisamitsu
    Mylan
    GSK
    Novartis
    Teve (Actavis)
    Johnson & Johnson
    Lohmann
    Teikoku Seiyaku
    Bayer
    Lingrui
    Sanofi
    Qizheng
    Endo
    Huarun 999
    Haw Par
    Nichiban
    Mentholatum
    Laboratoires Genevrier

Key Questions Answered
1. How big is the global Transdermal Drug Delivery System market?
2. What is the demand of the global Transdermal Drug Delivery System market?
3. What is the year over year growth of the global Transdermal Drug Delivery System market?
4. What is the total value of the global Transdermal Drug Delivery System market?
5. Who are the major players in the global Transdermal Drug Delivery System market?

Table of Contents

1 Supply Summary
    1.1 Transdermal Drug Delivery System Introduction
    1.2 World Transdermal Drug Delivery System Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Transdermal Drug Delivery System Total Market by Region (by Headquarter Location)
        1.3.1 World Transdermal Drug Delivery System Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Transdermal Drug Delivery System Market Size (2019-2030)
        1.3.3 China Transdermal Drug Delivery System Market Size (2019-2030)
        1.3.4 Europe Transdermal Drug Delivery System Market Size (2019-2030)
        1.3.5 Japan Transdermal Drug Delivery System Market Size (2019-2030)
        1.3.6 South Korea Transdermal Drug Delivery System Market Size (2019-2030)
        1.3.7 ASEAN Transdermal Drug Delivery System Market Size (2019-2030)
        1.3.8 India Transdermal Drug Delivery System Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Transdermal Drug Delivery System Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Transdermal Drug Delivery System Major Market Trends

2 Demand Summary
    2.1 World Transdermal Drug Delivery System Consumption Value (2019-2030)
    2.2 World Transdermal Drug Delivery System Consumption Value by Region
        2.2.1 World Transdermal Drug Delivery System Consumption Value by Region (2019-2024)
        2.2.2 World Transdermal Drug Delivery System Consumption Value Forecast by Region (2025-2030)
    2.3 United States Transdermal Drug Delivery System Consumption Value (2019-2030)
    2.4 China Transdermal Drug Delivery System Consumption Value (2019-2030)
    2.5 Europe Transdermal Drug Delivery System Consumption Value (2019-2030)
    2.6 Japan Transdermal Drug Delivery System Consumption Value (2019-2030)
    2.7 South Korea Transdermal Drug Delivery System Consumption Value (2019-2030)
    2.8 ASEAN Transdermal Drug Delivery System Consumption Value (2019-2030)
    2.9 India Transdermal Drug Delivery System Consumption Value (2019-2030)

3 World Transdermal Drug Delivery System Companies Competitive Analysis
    3.1 World Transdermal Drug Delivery System Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Transdermal Drug Delivery System Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Transdermal Drug Delivery System in 2023
        3.2.3 Global Concentration Ratios (CR8) for Transdermal Drug Delivery System in 2023
    3.3 Transdermal Drug Delivery System Company Evaluation Quadrant
    3.4 Transdermal Drug Delivery System Market: Overall Company Footprint Analysis
        3.4.1 Transdermal Drug Delivery System Market: Region Footprint
        3.4.2 Transdermal Drug Delivery System Market: Company Product Type Footprint
        3.4.3 Transdermal Drug Delivery System Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Transdermal Drug Delivery System Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Transdermal Drug Delivery System Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Transdermal Drug Delivery System Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Transdermal Drug Delivery System Consumption Value Comparison
        4.2.1 United States VS China: Transdermal Drug Delivery System Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Transdermal Drug Delivery System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Transdermal Drug Delivery System Companies and Market Share, 2019-2024
        4.3.1 United States Based Transdermal Drug Delivery System Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Transdermal Drug Delivery System Revenue, (2019-2024)
    4.4 China Based Companies Transdermal Drug Delivery System Revenue and Market Share, 2019-2024
        4.4.1 China Based Transdermal Drug Delivery System Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Transdermal Drug Delivery System Revenue, (2019-2024)
    4.5 Rest of World Based Transdermal Drug Delivery System Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Transdermal Drug Delivery System Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Transdermal Drug Delivery System Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Transdermal Drug Delivery System Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Fentanyl
        5.2.2 Nitroglycerin
        5.2.3 Estradiol
        5.2.4 Nicotine
        5.2.5 Other
    5.3 Market Segment by Type
        5.3.1 World Transdermal Drug Delivery System Market Size by Type (2019-2024)
        5.3.2 World Transdermal Drug Delivery System Market Size by Type (2025-2030)
        5.3.3 World Transdermal Drug Delivery System Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Transdermal Drug Delivery System Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 OTC
        6.2.2 Rx
    6.3 Market Segment by Application
        6.3.1 World Transdermal Drug Delivery System Market Size by Application (2019-2024)
        6.3.2 World Transdermal Drug Delivery System Market Size by Application (2025-2030)
        6.3.3 World Transdermal Drug Delivery System Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Hisamitsu
        7.1.1 Hisamitsu Details
        7.1.2 Hisamitsu Major Business
        7.1.3 Hisamitsu Transdermal Drug Delivery System Product and Services
        7.1.4 Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Hisamitsu Recent Developments/Updates
        7.1.6 Hisamitsu Competitive Strengths & Weaknesses
    7.2 Mylan
        7.2.1 Mylan Details
        7.2.2 Mylan Major Business
        7.2.3 Mylan Transdermal Drug Delivery System Product and Services
        7.2.4 Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Mylan Recent Developments/Updates
        7.2.6 Mylan Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Transdermal Drug Delivery System Product and Services
        7.3.4 GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Transdermal Drug Delivery System Product and Services
        7.4.4 Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Teve (Actavis)
        7.5.1 Teve (Actavis) Details
        7.5.2 Teve (Actavis) Major Business
        7.5.3 Teve (Actavis) Transdermal Drug Delivery System Product and Services
        7.5.4 Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Teve (Actavis) Recent Developments/Updates
        7.5.6 Teve (Actavis) Competitive Strengths & Weaknesses
    7.6 Johnson & Johnson
        7.6.1 Johnson & Johnson Details
        7.6.2 Johnson & Johnson Major Business
        7.6.3 Johnson & Johnson Transdermal Drug Delivery System Product and Services
        7.6.4 Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Johnson & Johnson Recent Developments/Updates
        7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.7 Lohmann
        7.7.1 Lohmann Details
        7.7.2 Lohmann Major Business
        7.7.3 Lohmann Transdermal Drug Delivery System Product and Services
        7.7.4 Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Lohmann Recent Developments/Updates
        7.7.6 Lohmann Competitive Strengths & Weaknesses
    7.8 Teikoku Seiyaku
        7.8.1 Teikoku Seiyaku Details
        7.8.2 Teikoku Seiyaku Major Business
        7.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Product and Services
        7.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Teikoku Seiyaku Recent Developments/Updates
        7.8.6 Teikoku Seiyaku Competitive Strengths & Weaknesses
    7.9 Bayer
        7.9.1 Bayer Details
        7.9.2 Bayer Major Business
        7.9.3 Bayer Transdermal Drug Delivery System Product and Services
        7.9.4 Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Bayer Recent Developments/Updates
        7.9.6 Bayer Competitive Strengths & Weaknesses
    7.10 Lingrui
        7.10.1 Lingrui Details
        7.10.2 Lingrui Major Business
        7.10.3 Lingrui Transdermal Drug Delivery System Product and Services
        7.10.4 Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Lingrui Recent Developments/Updates
        7.10.6 Lingrui Competitive Strengths & Weaknesses
    7.11 Sanofi
        7.11.1 Sanofi Details
        7.11.2 Sanofi Major Business
        7.11.3 Sanofi Transdermal Drug Delivery System Product and Services
        7.11.4 Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Sanofi Recent Developments/Updates
        7.11.6 Sanofi Competitive Strengths & Weaknesses
    7.12 Qizheng
        7.12.1 Qizheng Details
        7.12.2 Qizheng Major Business
        7.12.3 Qizheng Transdermal Drug Delivery System Product and Services
        7.12.4 Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Qizheng Recent Developments/Updates
        7.12.6 Qizheng Competitive Strengths & Weaknesses
    7.13 Endo
        7.13.1 Endo Details
        7.13.2 Endo Major Business
        7.13.3 Endo Transdermal Drug Delivery System Product and Services
        7.13.4 Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Endo Recent Developments/Updates
        7.13.6 Endo Competitive Strengths & Weaknesses
    7.14 Huarun 999
        7.14.1 Huarun 999 Details
        7.14.2 Huarun 999 Major Business
        7.14.3 Huarun 999 Transdermal Drug Delivery System Product and Services
        7.14.4 Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Huarun 999 Recent Developments/Updates
        7.14.6 Huarun 999 Competitive Strengths & Weaknesses
    7.15 Haw Par
        7.15.1 Haw Par Details
        7.15.2 Haw Par Major Business
        7.15.3 Haw Par Transdermal Drug Delivery System Product and Services
        7.15.4 Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Haw Par Recent Developments/Updates
        7.15.6 Haw Par Competitive Strengths & Weaknesses
    7.16 Nichiban
        7.16.1 Nichiban Details
        7.16.2 Nichiban Major Business
        7.16.3 Nichiban Transdermal Drug Delivery System Product and Services
        7.16.4 Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Nichiban Recent Developments/Updates
        7.16.6 Nichiban Competitive Strengths & Weaknesses
    7.17 Mentholatum
        7.17.1 Mentholatum Details
        7.17.2 Mentholatum Major Business
        7.17.3 Mentholatum Transdermal Drug Delivery System Product and Services
        7.17.4 Mentholatum Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Mentholatum Recent Developments/Updates
        7.17.6 Mentholatum Competitive Strengths & Weaknesses
    7.18 Laboratoires Genevrier
        7.18.1 Laboratoires Genevrier Details
        7.18.2 Laboratoires Genevrier Major Business
        7.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Product and Services
        7.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Laboratoires Genevrier Recent Developments/Updates
        7.18.6 Laboratoires Genevrier Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Transdermal Drug Delivery System Industry Chain
    8.2 Transdermal Drug Delivery System Upstream Analysis
    8.3 Transdermal Drug Delivery System Midstream Analysis
    8.4 Transdermal Drug Delivery System Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Transdermal Drug Delivery System Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Transdermal Drug Delivery System Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Transdermal Drug Delivery System Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Transdermal Drug Delivery System Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Transdermal Drug Delivery System Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Transdermal Drug Delivery System Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Transdermal Drug Delivery System Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Transdermal Drug Delivery System Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Transdermal Drug Delivery System Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Transdermal Drug Delivery System Players in 2023
    Table 12. World Transdermal Drug Delivery System Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Transdermal Drug Delivery System Company Evaluation Quadrant
    Table 14. Head Office of Key Transdermal Drug Delivery System Player
    Table 15. Transdermal Drug Delivery System Market: Company Product Type Footprint
    Table 16. Transdermal Drug Delivery System Market: Company Product Application Footprint
    Table 17. Transdermal Drug Delivery System Mergers & Acquisitions Activity
    Table 18. United States VS China Transdermal Drug Delivery System Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Transdermal Drug Delivery System Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Transdermal Drug Delivery System Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Transdermal Drug Delivery System Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Transdermal Drug Delivery System Revenue Market Share (2019-2024)
    Table 23. China Based Transdermal Drug Delivery System Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Transdermal Drug Delivery System Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Transdermal Drug Delivery System Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Transdermal Drug Delivery System Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Transdermal Drug Delivery System Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Transdermal Drug Delivery System Revenue Market Share (2019-2024)
    Table 29. World Transdermal Drug Delivery System Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Transdermal Drug Delivery System Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Transdermal Drug Delivery System Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Transdermal Drug Delivery System Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Transdermal Drug Delivery System Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Transdermal Drug Delivery System Market Size by Application (2025-2030) & (USD Million)
    Table 35. Hisamitsu Basic Information, Area Served and Competitors
    Table 36. Hisamitsu Major Business
    Table 37. Hisamitsu Transdermal Drug Delivery System Product and Services
    Table 38. Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Hisamitsu Recent Developments/Updates
    Table 40. Hisamitsu Competitive Strengths & Weaknesses
    Table 41. Mylan Basic Information, Area Served and Competitors
    Table 42. Mylan Major Business
    Table 43. Mylan Transdermal Drug Delivery System Product and Services
    Table 44. Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Mylan Recent Developments/Updates
    Table 46. Mylan Competitive Strengths & Weaknesses
    Table 47. GSK Basic Information, Area Served and Competitors
    Table 48. GSK Major Business
    Table 49. GSK Transdermal Drug Delivery System Product and Services
    Table 50. GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. GSK Recent Developments/Updates
    Table 52. GSK Competitive Strengths & Weaknesses
    Table 53. Novartis Basic Information, Area Served and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis Transdermal Drug Delivery System Product and Services
    Table 56. Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Novartis Competitive Strengths & Weaknesses
    Table 59. Teve (Actavis) Basic Information, Area Served and Competitors
    Table 60. Teve (Actavis) Major Business
    Table 61. Teve (Actavis) Transdermal Drug Delivery System Product and Services
    Table 62. Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Teve (Actavis) Recent Developments/Updates
    Table 64. Teve (Actavis) Competitive Strengths & Weaknesses
    Table 65. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 66. Johnson & Johnson Major Business
    Table 67. Johnson & Johnson Transdermal Drug Delivery System Product and Services
    Table 68. Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Johnson & Johnson Recent Developments/Updates
    Table 70. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 71. Lohmann Basic Information, Area Served and Competitors
    Table 72. Lohmann Major Business
    Table 73. Lohmann Transdermal Drug Delivery System Product and Services
    Table 74. Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Lohmann Recent Developments/Updates
    Table 76. Lohmann Competitive Strengths & Weaknesses
    Table 77. Teikoku Seiyaku Basic Information, Area Served and Competitors
    Table 78. Teikoku Seiyaku Major Business
    Table 79. Teikoku Seiyaku Transdermal Drug Delivery System Product and Services
    Table 80. Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Teikoku Seiyaku Recent Developments/Updates
    Table 82. Teikoku Seiyaku Competitive Strengths & Weaknesses
    Table 83. Bayer Basic Information, Area Served and Competitors
    Table 84. Bayer Major Business
    Table 85. Bayer Transdermal Drug Delivery System Product and Services
    Table 86. Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Bayer Recent Developments/Updates
    Table 88. Bayer Competitive Strengths & Weaknesses
    Table 89. Lingrui Basic Information, Area Served and Competitors
    Table 90. Lingrui Major Business
    Table 91. Lingrui Transdermal Drug Delivery System Product and Services
    Table 92. Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Lingrui Recent Developments/Updates
    Table 94. Lingrui Competitive Strengths & Weaknesses
    Table 95. Sanofi Basic Information, Area Served and Competitors
    Table 96. Sanofi Major Business
    Table 97. Sanofi Transdermal Drug Delivery System Product and Services
    Table 98. Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Sanofi Recent Developments/Updates
    Table 100. Sanofi Competitive Strengths & Weaknesses
    Table 101. Qizheng Basic Information, Area Served and Competitors
    Table 102. Qizheng Major Business
    Table 103. Qizheng Transdermal Drug Delivery System Product and Services
    Table 104. Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Qizheng Recent Developments/Updates
    Table 106. Qizheng Competitive Strengths & Weaknesses
    Table 107. Endo Basic Information, Area Served and Competitors
    Table 108. Endo Major Business
    Table 109. Endo Transdermal Drug Delivery System Product and Services
    Table 110. Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Endo Recent Developments/Updates
    Table 112. Endo Competitive Strengths & Weaknesses
    Table 113. Huarun 999 Basic Information, Area Served and Competitors
    Table 114. Huarun 999 Major Business
    Table 115. Huarun 999 Transdermal Drug Delivery System Product and Services
    Table 116. Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Huarun 999 Recent Developments/Updates
    Table 118. Huarun 999 Competitive Strengths & Weaknesses
    Table 119. Haw Par Basic Information, Area Served and Competitors
    Table 120. Haw Par Major Business
    Table 121. Haw Par Transdermal Drug Delivery System Product and Services
    Table 122. Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Haw Par Recent Developments/Updates
    Table 124. Haw Par Competitive Strengths & Weaknesses
    Table 125. Nichiban Basic Information, Area Served and Competitors
    Table 126. Nichiban Major Business
    Table 127. Nichiban Transdermal Drug Delivery System Product and Services
    Table 128. Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Nichiban Recent Developments/Updates
    Table 130. Nichiban Competitive Strengths & Weaknesses
    Table 131. Mentholatum Basic Information, Area Served and Competitors
    Table 132. Mentholatum Major Business
    Table 133. Mentholatum Transdermal Drug Delivery System Product and Services
    Table 134. Mentholatum Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 135. Mentholatum Recent Developments/Updates
    Table 136. Laboratoires Genevrier Basic Information, Area Served and Competitors
    Table 137. Laboratoires Genevrier Major Business
    Table 138. Laboratoires Genevrier Transdermal Drug Delivery System Product and Services
    Table 139. Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 140. Global Key Players of Transdermal Drug Delivery System Upstream (Raw Materials)
    Table 141. Transdermal Drug Delivery System Typical Customers
List of Figure
    Figure 1. Transdermal Drug Delivery System Picture
    Figure 2. World Transdermal Drug Delivery System Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Transdermal Drug Delivery System Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Transdermal Drug Delivery System Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Transdermal Drug Delivery System Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Transdermal Drug Delivery System Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Transdermal Drug Delivery System Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Transdermal Drug Delivery System Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Transdermal Drug Delivery System Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Transdermal Drug Delivery System Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Transdermal Drug Delivery System Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Transdermal Drug Delivery System Revenue (2019-2030) & (USD Million)
    Figure 13. Transdermal Drug Delivery System Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Transdermal Drug Delivery System Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Transdermal Drug Delivery System Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Transdermal Drug Delivery System by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Transdermal Drug Delivery System Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Transdermal Drug Delivery System Markets in 2023
    Figure 27. United States VS China: Transdermal Drug Delivery System Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Transdermal Drug Delivery System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Transdermal Drug Delivery System Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Transdermal Drug Delivery System Market Size Market Share by Type in 2023
    Figure 31. Fentanyl
    Figure 32. Nitroglycerin
    Figure 33. Estradiol
    Figure 34. Nicotine
    Figure 35. Other
    Figure 36. World Transdermal Drug Delivery System Market Size Market Share by Type (2019-2030)
    Figure 37. World Transdermal Drug Delivery System Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 38. World Transdermal Drug Delivery System Market Size Market Share by Application in 2023
    Figure 39. OTC
    Figure 40. Rx
    Figure 41. Transdermal Drug Delivery System Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier